Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04494048 · ClinicalTrials.gov registry record

Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry

A clinical trial of Obesity and Weight Loss, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
1
Study location

NCT04494048: Recruiting study of Obesity and Weight Loss, sponsored by Weill Medical College of Cornell University.

NCT04494048 is a study of Obesity and Weight Loss that is actively recruiting participants, run by Weill Medical College of Cornell University. The registry lists this as an open-ended (no fixed target) study. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04494048, a study of Obesity and Weight Loss, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
open-ended (no fixed target)
Enrollment target
1
Study location

Study Summary

The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care visits up to 1 years after a subject consents for study participation.

Primary Outcome

Compare mean percentage total body weight loss achieved via various Endoscopic Bariatric Therapies compared to baseline, 1 month, 6 months and 1 . year post procedure. This will be calculated by measuring the patients weight on a scale and comparing it to their baseline weight pre procedure.

Interventions

  • OTHER Endoscopic Bariatric Therapies

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target open-ended (no fixed target)
Start Date 2016-04-05
Est. Completion 2035-10-31

What NCT04494048 shows while recruiting

NCT04494048 is an observational study that tracks outcomes without assigning an intervention. The registry lists this as an open-ended (no fixed target) study, common for long-running registries that collect data indefinitely.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Bariatric Therapies is the first listed.

NCT04494048 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04494048 about?

NCT04494048 is a clinical study titled "Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry". The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care vis...

What is the current status of trial NCT04494048?

This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 2016-04-05. Estimated completion is 2035-10-31.

What conditions does trial NCT04494048 study?

This clinical trial studies the following conditions: Obesity, Weight Loss, Gastroesophageal Reflux, Bariatric Surgery Candidate.

What interventions are being tested in trial NCT04494048?

The interventions under investigation include: Endoscopic Bariatric Therapies (OTHER).

Who is sponsoring clinical trial NCT04494048?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04494048 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04494048, the US trial registry maintained by the National Library of Medicine. NCT04494048 (unsized enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.